You are here

Vaccinations

Ebola: Uganda locks down two districts, Indian company to produce an experimental vaccine for Uganda's outbreak

Mon, 2022-10-17 19:24 — mike kraft

Uganda locks down 2 districts in bid to stem spread of Ebola KAMPALA, Uganda (AP) — Ugandan authorities on Saturday imposed a travel lockdown on two Ebola-hit districts as part of efforts to stop the spread of the contagious disease. The measures announced by President Yoweri Museveni mean residents of the central Ugandan districts of Mubende and Kassanda can't travel into or out of those areas by private or public means. AP NEWS

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Moderna will provide variant-adapted COVID shots for world's poorest

Mon, 2022-10-17 13:31 — mike kraft

Moderna signs deal on variant-adapted COVID shots for world's poorest Moderna Inc (MRNA.O) has agreed to provide its new variant-adapted COVID-19 vaccine to the global scheme aiming to deliver shots to the world's poorest people. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Moderna will provide variant-adapted COVID shots for world's poorest
Log in or register to post comments

Key Cholara vaccine production to be discontinued, causing official dismay

Fri, 2022-10-14 22:43 — mike kraft

Dismay as key cholera vaccine is discontinued Exclusive: halt to production of Shanchol vaccine alarms WHO amid ‘unprecedented’ global outbreaks the Guardian

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Key Cholara vaccine production to be discontinued, causing official dismay
Log in or register to post comments

Monkeypox treatment trial begins in the Democratic Republic of the Congo

Fri, 2022-10-14 15:55 — mike kraft

Monkeypox treatment trial begins in the Democratic Republic of the NIH partnering with INRB to evaluate tecovirimat (TPOXX). National Institutes of Health (NIH)

...

The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death.

...

Country / Region Tags:

Democratic Republic of the Congo

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Monkeypox treatment trial begins in the Democratic Republic of the Congo
Log in or register to post comments

U.S. Monkeypox response looks to long term strategies

Fri, 2022-10-14 15:28 — mike kraft

Monkeypox response looks to long term - Roll Call Federal officials warn that monkeypox is here to stay, but hope to use a combination of strategies to limit the spread of the virus. Roll Call

Federal officials look to vaccines, treatment, education to limit spread

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. Monkeypox response looks to long term strategies
Log in or register to post comments

Vaccine trials on Sudan Ebola strain to start in weeks - WHO chief

Thu, 2022-10-13 22:07 — mike kraft

Vaccine trials on Sudan Ebola strain to start in weeks - WHO chief World Health Organization chief Tedros Adhanom Ghebreyesus said on Wednesday a clinical trial of vaccines to combat the Sudan strain of Ebola could start within weeks as an outbreak of the disease in Uganda reached the capital, stirring alarm. Elias Biryabarema Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vaccine trials on Sudan Ebola strain to start in weeks - WHO chief
Log in or register to post comments

Pfizer, BioNTech's updated booster protects against Omicron in human trial

Thu, 2022-10-13 15:14 — mike kraft

Pfizer, BioNTech's updated booster protects against Omicron in human trial Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants, generated a strong immune response and was well tolerated in testing on humans. Ludwig Burger,Manas Mishra Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer, BioNTech's updated booster protects against Omicron in human trial
Log in or register to post comments

Discussion of what Covid-19 precautions people shoukd take for international travel

Thu, 2022-10-13 00:31 — mike kraft

What Covid-19 precautions should people take for international travel? Last week, the US Centers for Disease Control and Prevention announced it would no longer be maintaining a country-by-country travel advisory of Covid-19 risk. Instead of assessing the level of Covid-19 infection in each country, the CDC will post notices only when there are new variants or other situations that would change its travel recommendations. By Katia Hetter, CNN CNN

..

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Medical Testing

Public Attitudes

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Discussion of what Covid-19 precautions people shoukd take for international travel
Log in or register to post comments

Novavax says its COVID booster dose shows benefit against Omicron variants

Wed, 2022-10-12 23:08 — mike kraft

Novavax says COVID booster dose shows benefit against Omicron variants Novavax Inc said on Wednesday data from studies in adults and adolescents showed that the booster dose of its COVID vaccine produced robust antibodies against several Omicron variants, including BA.1, BA.2 and BA.5. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax says its COVID booster dose shows benefit against Omicron variants
Log in or register to post comments

U.S. FDA clears updated COVID boosters for kids as young as 5

Wed, 2022-10-12 17:17 — mike kraft

FDA clears updated COVID boosters for kids as young as 5 The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave. Tweaked boosters rolled out for Americans 12 and older last month, doses modified to target today’s most common and contagious omicron relative . AP NEWS

...

There’s one more step before parents can bring their kids in for the new shot: The Centers for Disease Control and Prevention, which recommends how vaccines are used, must sign off.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA clears updated COVID boosters for kids as young as 5
Log in or register to post comments

Pages

Page loaded in 0.807 seconds.